Instituto Nacional De Cancerologia De Mexico

This study tests whether the drug tocilizumab can help people with severe or critical COVID-19. About 200 adults with serious breathing problems will receive one or two doses and be followed for 30 days. The goal is to see if the drug improves survival and reduces lung damage.

This study tests whether using a special breathing device (AEROBIKA) after chest surgery can reduce the chance of a collapsed lung (atelectasis) in people with lung cancer or other chest tumors. About 72 participants will either get standard rehab or standard rehab plus the devic…